Zivo Bioscience, Inc. Warrants
ZIVOW
ZIVOW was delisted on the 24th of November, 2023.
5 hedge funds and large institutions have $99K invested in Zivo Bioscience, Inc. Warrants in 2022 Q3 according to their latest regulatory filings, with funds opening new positions, 2 increasing their positions, 0 reducing their positions, and closing their positions.
60% more capital invested
Capital invested by funds: $62K → $99K (+$37K)
0% more funds holding
Funds holding: 5 → 5 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WAM
Warberg Asset Management
Winnetka,
Illinois
|
+$57.8K |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$1.46K |
Top Sellers
ZIVOW Hedge Fund Activity: Q3 2022 in Review
5 of the 5,828 institutional investors tracked by Wall St. Rank reported a position in Zivo Bioscience, Inc. Warrants (ZIVOW) for Q3 2022, worth a combined $99K — up 60% from $62K a quarter earlier.
Fund positioning in ZIVOW was balanced in Q3 2022: 0 funds opened new positions, 0 closed out, 2 added to existing stakes and 0 trimmed.
The largest buyer was Warberg Asset Management, adding an estimated $57.8K.
- 5 institutional investors held Zivo Bioscience, Inc. Warrants (ZIVOW) as of Q3 2022, unchanged from Q2 2022.
- Funds reported $99K of Zivo Bioscience, Inc. Warrants stock for Q3 2022, up 60% quarter-over-quarter.
- 0 funds opened new Zivo Bioscience, Inc. Warrants positions in Q3 2022 and 0 closed out.
- The largest Zivo Bioscience, Inc. Warrants buyer in Q3 2022 was Warberg Asset Management, an estimated $57.8K added.
Based on aggregated 13F filings for Q3 2022.